S&P 500 7,498.96 -0.14% NASDAQ 25,690.90 -0.57% DOW 52,218.58 -0.01% R2K 2,959.94 -0.92% VIX 16.64 -2.40% US 10Y 4.66 +0.63% DXY 101.14 -0.04% GOLD 4,120.70 +1.22% CRUDE 87.95 +3.58% BITCOIN 65,868.00 -0.96%
Next Bullish Trade
Sign in
WST

West Pharmaceutical Services, Inc. NYQ · WST

$358.41 -0.83 (-0.23%)
Neutral · +0.75σ Grade C
+ Compare Open in Sniper

Price chart

Timeframe
Range
Fundamentals · free Click ▲ earnings markers (daily) for the day's move

Loading…

Latest bar · WST

Momentum reads · latest daily bar
Last
$358.41
-0.83 (-0.23%)
Mkt cap
$25.3B
Healthcare
RSI(14)
59.4
neutral
Stochastic %K
45.2
neutral
MFI(14)
47.1
neutral
ADX(14)
26.7
trending

Green means room to run, red means stretched — the reads re-read live as you switch the chart's timeframe. MFI(14) is a volume-weighted money-flow read: above 80 = overbought, below 20 = oversold.

Financial overlay · last 12 quarters

The story behind the price: three years of quarterly results laid over the chart, so you can see whether the stock has been following the business — or running ahead of it.

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $0.8B $0.1B $0.2B $0.0B 16.4% 21.4%
2025-12-31 $0.8B $0.1B $0.2B $0.2B 16.4% 21.8%
2025-09-30 $0.8B $0.1B $0.2B $0.1B 17.4% 21.7%
2025-06-30 $0.8B $0.1B $0.2B $0.1B 17.2% 20.7%
2025-03-31 $0.7B $0.1B $0.1B $0.1B 12.9% 18.3%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%

Tip: toggle P/E, FCF, ROE, Gross margin and more on the chart above — every overlay is free.

Compare WST vs peers

Line WST up against up to 4 peers (5 tickers total) across ~30 metrics and get one weighted 0-100 verdict — best in green, worst in red. Peers also overlay on the chart above as rebased % lines, or flip the chart to the 2×2 grid for side-by-side mini charts.

Comparing WST no peers yet — add up to 4 below
Sector peers + LLY + UNH + JNJ + MRK + ABBV + PFE
Popular + AAPL + MSFT + NVDA + AMZN + GOOG + META + TSLA + AVGO
Matchups NVDA · AMD · AVGO · SMCI · MU AAPL · MSFT · GOOG · META · AMZN JPM · GS · MS · BAC · C TSLA · RIVN · LCID · GM · F XOM · CVX · OXY · COP

Add tickers to compare with WST

~30 metrics across Snapshot, OdysseyHQ zone, Valuation, Growth, Quality, Technicals, Sentiment, and Risk — with a weighted score and a one-line read on each.

Earnings replay · last 20 reports

How this stock actually behaves on report day: each past earnings print with the beat-or-miss and the next-day move — a track record for handicapping the next one.

DateEPS actual EPS estSurprise Next-day
2026-04-23 2.13 1.68 +27.1% -1.1%
2026-02-12 2.04 1.83 +11.5% +2.8%
2025-10-23 1.96 1.71 +14.6% -3.2%
2025-07-24 1.84 1.54 +19.7% -5.6%
2025-04-24 1.45 1.26 +15.3% +1.9%
2025-02-13 1.82 1.73 +5.3% +7.8%
2024-10-24 1.85 1.49 +23.8% -6.9%
2024-07-25 1.52 1.73 -12.1% +2.7%
2024-04-25 1.56 1.29 +21.2% -2.1%
2024-02-15 1.83 1.78 +2.7% +3.2%
2023-10-26 2.16 1.86 +16.2% -2.0%
2023-07-27 2.11 1.93 +9.5% +3.0%
2023-04-27 1.98 1.67 +18.8% +1.7%
2023-02-16 1.77 1.38 +28.6% -1.9%
2022-10-27 2.03 2.12 -4.2% +1.9%
2022-07-28 2.47 2.21 +11.9% +1.1%
2022-04-28 2.30 2.12 +8.5% -3.2%
2022-02-17 2.04 1.92 +6.5% -4.6%
2021-10-28 2.06 1.80 +14.6% +2.1%
2021-07-29 2.46 1.74 +41.4% +1.7%

Earnings markers are overlaid on the daily price chart above. Click a ▲ marker for that day's move.

Peer comparison · Healthcare

Context check: the same key numbers for the closest Healthcare names side by side, so you can tell whether this stock is the standout or just moving with its group.

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
WST ★ $25B 48.0 37.3 7.9 28.9 8.5 36.3% 21.0% 56.1% 1.09%
LLY $1,037B 41.4 25.9 — 30.0 33.3 82.8% 55.5% 169.9% 0.88%
UNH $392B 32.5 19.2 0.9 18.1 3.7 19.5% 0.4% 61.5% 5.81%
JNJ $615B 29.7 19.9 6.3 18.3 7.6 68.1% 6.6% -1.0% —
MRK $315B 35.9 13.2 — 12.0 6.9 76.7% 4.9% — 4.46%
ABBV $448B 123.6 15.6 7.1 17.2 -67.2 72.0% 12.4% -46.2% 4.65%
PFE $141B 18.9 8.8 — 7.6 1.6 74.8% 5.4% -10.1% 8.75%
TMO $196B 29.0 19.3 — 20.8 3.8 40.9% 6.2% 11.3% 2.82%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Who holds the stock and what they've been doing lately — big funds on the left, executives' own buys and sells on the right. Insider buying is the rarer, louder signal.

Top institutional holders

Top-10 concentration: 45.27%

HolderShares% out
Blackrock Inc. 6,836,714 9.68%
Vanguard Capital Management LLC 4,683,286 6.63%
Vanguard Portfolio Management LLC 4,094,009 5.79%
State Street Corporation 3,293,778 4.66%
Artisan Partners Limited Partnership 2,657,893 3.76%
Bank Of New York Mellon Corporation 2,465,858 3.49%
T. Rowe Price Investment Management, 2,340,403 3.31%
Generation Investment Management LLP 2,243,976 3.18%
Geode Capital Management, LLC 1,912,455 2.71%
Morgan Stanley 1,458,282 2.06%

Insider activity · 90d

9 buys / 0 sells · ratio 9.0 · Finnhub

  • HAUGEN JANET BRUTSCHEA BUY 307 @ $359.00
  • Campbell Shane Alden M 1,417
  • Campbell Shane Alden M 886
  • Campbell Shane Alden F 613 @ $312.07
  • Campbell Shane Alden M 748
  • Campbell Shane Alden F 274 @ $312.07
  • Campbell Shane Alden M 358
  • FRIEL ROBERT F BUY 5,513
  • Feehery William F BUY 32,519
  • Pucci Paolo BUY 11,854

Analyst estimates

Finnhub

What Wall Street expects next: the consensus forecasts for the coming quarters. The market usually reacts to results versus these numbers, not the raw results themselves.

Low
$310.0
Mean
$385.33334
High
$447.0
Analysts
15
Recommendation distribution · period 2026-07-01
8
12
2
Revision trend (2026-04-01 → 2026-07-01): net 18 → 20 +2 (net = strong_buy+buy − sell−strong_sell)

SEC filings

The company's own paperwork, straight from the regulator — annual and quarterly reports, big announcements and insider trades. The primary source behind every headline.

FormFiled DescriptionAction
8-K 2026-07-14 8-K view ·
4 2026-07-01 FORM 4 view ·
8-K 2026-06-01 8-K view ·
4 2026-05-14 PRIMARY DOCUMENT view ·
8-K 2026-05-11 8-K view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
4 2026-05-06 PRIMARY DOCUMENT view ·
8-K 2026-05-05 8-K view ·
4 2026-04-29 PRIMARY DOCUMENT view ·
4 2026-04-29 PRIMARY DOCUMENT view ·
10-Q 2026-04-23 10-Q view ·
8-K 2026-04-23 8-K view ·
4 2026-04-01 PRIMARY DOCUMENT view ·
DEF 14A 2026-03-12 DEF 14A view ·
8-K 2026-03-09 8-K view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-03-03 PRIMARY DOCUMENT view ·
4 2026-02-23 PRIMARY DOCUMENT view ·
4 2026-02-23 PRIMARY DOCUMENT view ·
4 2026-02-23 PRIMARY DOCUMENT view ·
4 2026-02-19 PRIMARY DOCUMENT view ·
4 2026-02-19 PRIMARY DOCUMENT view ·
4 2026-02-19 PRIMARY DOCUMENT view ·
4 2026-02-19 PRIMARY DOCUMENT view ·
4 2026-02-19 PRIMARY DOCUMENT view ·
10-K 2026-02-17 10-K view ·
4 2026-02-12 PRIMARY DOCUMENT view ·
8-K 2026-02-12 8-K view ·
4 2026-01-05 PRIMARY DOCUMENT view ·
4 2025-12-10 PRIMARY DOCUMENT view ·
10-Q 2025-10-23 10-Q view ·
8-K 2025-10-23 8-K view ·
4 2025-10-02 PRIMARY DOCUMENT view ·
8-K 2025-09-11 8-K view ·
4 2025-08-12 PRIMARY DOCUMENT view ·
10-Q 2025-07-24 10-Q view ·
8-K 2025-07-24 8-K view ·
8-K 2025-07-21 8-K view ·
4 2025-07-01 PRIMARY DOCUMENT view ·
4 2025-05-14 PRIMARY DOCUMENT view ·
4 2025-05-08 PRIMARY DOCUMENT view ·
4 2025-05-08 PRIMARY DOCUMENT view ·
4 2025-05-08 PRIMARY DOCUMENT view ·
4 2025-05-08 PRIMARY DOCUMENT view ·
8-K 2025-05-08 8-K view ·
4 2025-05-08 PRIMARY DOCUMENT view ·
4 2025-05-08 PRIMARY DOCUMENT view ·

About WST

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-…

Options picks · WST

ITM + OTM ideas from the latest scan

Loading…

Congress trades · WST

STOCK Act disclosures

Loading…

SEC filings & insiders · WST

EDGAR · live

Loading…

Holders · WST

Institutions & insider activity

Loading…